ELV- Elevance Health, Inc.
Healthcare · Healthcare Plans
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
BuyWall Street consensus from 21 analysts
12-Month Price Target
$450.05
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $418.72
Graham Number
√(22.5 × EPS × Book Value)
$324.50
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$96.40
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
8/10
80% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
11.1%Return on equity - measures how efficiently capital is used
Positive profit margin
2.5%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
+1.4%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
-13.1%Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
68.95×Low financial leverage reduces risk of distress
Current ratio above 1
1.52×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$556M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
1.64%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Oct 21, 2026
39
days
EPS (TTM)
$22.61
P/E (TTM)
18.5
Fwd P/E
14.1
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
1.64%
5Y Avg Annual
$5.9120
Last Payment
$1.7200
Ex-Date
09/10/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest09/10/2026 | 09/25/2026 | $1.7200 | 1.64% |
06/10/2026 | 06/25/2026 | $1.7200 | 1.64% |
03/10/2026 | 03/25/2026 | $1.7200 | 1.64% |
12/05/2025 | 12/20/2025 | $1.7100 | 1.63% |
09/10/2025 | 09/25/2025 | $1.7100 | 1.63% |
06/10/2025 | 06/25/2025 | $1.7100 | 1.63% |
03/10/2025 | 03/25/2025 | $1.7100 | 1.63% |
12/05/2024 | 12/20/2024 | $1.6300 | 1.56% |
Magic Number
Shares needed to self-fund your next purchase
$418.72
Price
$1.7200
Last div. (quarterly)
244
shares
Own 244 ELV shares ($102,167.68) and each quarterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$102,167.68
New shares / year
+4 shares
Dividend Calculator
1.64% yieldEstimate ELV dividend income at the current rate.
Per year
$164.31
Per month
$13.69
≈ 23.9 shares at $6.88/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
ELV vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Elevance Health, Inc.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Sector
Healthcare
Industry
Healthcare Plans
Location
Indianapolis, United States
Employees
96,129
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Elevance Health, Inc. (ELV) stock trades at $418.72, up 0.52% on the day. With a market capitalization of $90.81 billion, ELV is a large-cap healthcare stock. It trades at a price-to-earnings (P/E) ratio of 18.5, a forward P/E of 14.1 and earnings per share (EPS) of $22.61. Over the most recent period the company reported 1% year-over-year revenue growth and a net profit margin of 2.5%. Below you'll find ELV's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
ELV - Frequently Asked Questions
Is Elevance Health, Inc. (ELV) a good stock to buy in 2026?
Elevance Health, Inc. (ELV) shows risks such as high leverage (debt/equity of 69.0). Whether ELV is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is ELV's stock price today?
Elevance Health, Inc. (ELV) trades at $418.72, up 0.52% on the session. Prices on this page update throughout the trading day.
Does ELV pay a dividend?
Yes. Elevance Health, Inc. pays an annual dividend of $6.88 per share, a dividend yield of 1.64%. The most recent ex-dividend date was September 10, 2026. Its payout ratio is about 30% of earnings.
Is ELV overvalued?
With a P/E ratio of 18.5×, ELV trades at a roughly market-average valuation for the healthcare sector. Its PEG ratio is 1.30. See the Fair Value Estimates section above for Graham Number and dividend-based price targets.
What is ELV's market cap?
Elevance Health, Inc. (ELV) has a market capitalization of $90.81 billion, classifying it as a large-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.